| scholarly article | Q13442814 |
| case report | Q2782326 |
| P6179 | Dimensions Publication ID | 1031292580 |
| P356 | DOI | 10.1186/S40661-016-0031-8 |
| P932 | PMC publication ID | 5078960 |
| P698 | PubMed publication ID | 28685778 |
| P2093 | author name string | Krishnansu S Tewari | |
| P2860 | cites work | Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer | Q71600170 |
| A radical operation for fixed ovarian tumours | Q72231905 | ||
| The surgical treatment of cancer of the ovary | Q79072080 | ||
| Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial | Q84574337 | ||
| Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | Q24633070 | ||
| Tumor angiogenesis: therapeutic implications | Q27860595 | ||
| Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer | Q27860857 | ||
| Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study | Q30359356 | ||
| Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G | Q33335882 | ||
| Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial | Q33413609 | ||
| Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis | Q33957687 | ||
| I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. | Q34687264 | ||
| Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper | Q36433053 | ||
| Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer | Q37368055 | ||
| Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma--mechanistics, review of phase III randomized clinical trials, and regulatory implications | Q38169470 | ||
| PARP inhibition and synthetic lethality in ovarian cancer | Q38225315 | ||
| Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer | Q38546360 | ||
| A review of HER2-targeted therapy in breast and ovarian cancer: lessons from antiquity - CLEOPATRA and PENELOPE. | Q38644521 | ||
| New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors | Q38756892 | ||
| Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian Cancer | Q38767880 | ||
| Pelvic exenteration for locally advanced and recurrent ovarian cancer. Review of 22 cases | Q40068851 | ||
| Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer | Q40673230 | ||
| Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer | Q41386447 | ||
| Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer | Q44461877 | ||
| Advanced cytoreductive surgery workshop report | Q48366790 | ||
| Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. | Q50512108 | ||
| Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma | Q52438885 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| Surgical Reduction of Tumour Bulk in Management of Abdominal Burkitt's Lymphoma | Q55205888 | ||
| Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation | Q56240758 | ||
| Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer | Q56807699 | ||
| P921 | main subject | ovarian cancer | Q172341 |
| workshop | Q27556165 | ||
| P304 | page(s) | 10 | |
| P577 | publication date | 2016-10-24 | |
| P1433 | published in | Gynecologic oncology research and practice | Q27727212 |
| P1476 | title | Fifth annual workshop of cytoreductive surgery for advanced ovarian cancer and peritoneal surface malignancies | |
| P478 | volume | 3 |
Search more.